Terms: = Liver cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
13 results:
1. LncRNA CEBPA-DT promotes liver cancer metastasis through ddr2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract] [Full Text] [Related]
2. Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations.
Ayala Soriano C; Benitez Barzaga M; Chhina A; Jain M; Nava VE
Diagn Cytopathol; 2022 Nov; 50(11):E310-E314. PubMed ID: 35765767
[TBL] [Abstract] [Full Text] [Related]
3. The portrait of liver cancer is shaped by mitochondrial genetics.
Chattopadhyay M; Jenkins EC; Lechuga-Vieco AV; Nie K; Fiel MI; Rialdi A; Guccione E; Enriquez JA; Sia D; Lujambio A; Germain D
Cell Rep; 2022 Jan; 38(3):110254. PubMed ID: 35045282
[TBL] [Abstract] [Full Text] [Related]
4. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
Front Immunol; 2021; 12():676922. PubMed ID: 34335575
[TBL] [Abstract] [Full Text] [Related]
5. Amplification of ddr2 mediates sorafenib resistance through NF-κB/c-Rel signaling in hepatocellular carcinoma.
Liu QQ; Liu YW; Xie YK; Zhang JH; Song CX; Wang JZ; Xie BH
Cell Biol Int; 2021 Sep; 45(9):1906-1916. PubMed ID: 33969575
[TBL] [Abstract] [Full Text] [Related]
6. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor ddr2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract] [Full Text] [Related]
7. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract] [Full Text] [Related]
8. ddr2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
[TBL] [Abstract] [Full Text] [Related]
10. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.
Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS
J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
Badiola I; Villacé P; Basaldua I; Olaso E
Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
[TBL] [Abstract] [Full Text] [Related]
12. Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition.
Maeyama M; Koga H; Selvendiran K; Yanagimoto C; Hanada S; Taniguchi E; Kawaguchi T; Harada M; Ueno T; Sata M
Cancer; 2008 Nov; 113(10):2823-31. PubMed ID: 18853422
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology of hepatocellular carcinoma in a province of northern Italy: prevalence of the risk factors and incidence in the population.
Mels GC; Leandro G; Scorpiniti A; Cristini P; Moretti GB; Di Nolfo AM; Angeli G
Tumori; 1993 Feb; 79(1):16-21. PubMed ID: 8388587
[TBL] [Abstract] [Full Text] [Related]